 Connection
Atsushi Oba to Prognosis
This is a "connection" page, showing publications Atsushi Oba has written about Prognosis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.269 |
|
|
|
-
Oba A, Shimane G, Makuuchi R, Kiritani S, Kobayashi K, Ri M, Ono Y, Hayami M, Irino T, Ito H, Inoue Y, Ohashi M, Nunobe S, Takahashi Y. Robotic Pancreatectomy as an Adjunct to Radical Gastrectomy for Advanced Gastric Cancer: Surgical and Clinical Implications. Ann Surg Oncol. 2026 Apr; 33(4):3473-3474.
Score: 0.125
-
Oba A, Bao QR, Barnett CC, Al-Musawi MH, Croce C, Schulick RD, Del Chiaro M. Vascular Resections for Pancreatic Ductal Adenocarcinoma: Vascular Resections for PDAC. Scand J Surg. 2020 Mar; 109(1):18-28.
Score: 0.083
-
Oba A, Inoue Y, Ono Y, Irie S, Sato T, Mise Y, Ito H, Takahashi Y, Saiura A. Radiologically occult metastatic pancreatic cancer: how can we avoid unbeneficial resection? Langenbecks Arch Surg. 2020 Feb; 405(1):35-41.
Score: 0.082
-
Oba A, Kudo A, Akahoshi K, Kishino M, Akashi T, Katsuta E, Iwao Y, Ono H, Mitsunori Y, Ban D, Tanaka S, Eishi Y, Tateishi U, Tanabe M. A simple morphological classification to estimate the malignant potential of pancreatic neuroendocrine tumors. J Gastroenterol. 2017 10; 52(10):1140-1146.
Score: 0.069
-
Oba A, Ban D, Kirimura S, Akahoshi K, Mitsunori Y, Matsumura S, Ochiai T, Kudo A, Tanaka S, Minoru T. Clinical application of the biomarkers for the selection of adjuvant chemotherapy in pancreatic ductal adenocarcinoma. J Hepatobiliary Pancreat Sci. 2016 Aug; 23(8):480-8.
Score: 0.065
-
Ito R, Oba A, Baba H, Shimane G, Sugiura K, Sawa Y, Shibata Y, Kiritani S, Kobayashi K, Ono Y, Inoue Y, Ito H, Yoshioka R, Mise Y, Saiura A, Takahashi Y. A Widely Applicable CAD-Based Intraoperative 3D Navigation Method for Hepatopancreatobiliary Surgery. Ann Surg Oncol. 2026 Apr; 33(4):3421-3422.
Score: 0.031
-
Miyata T, Oba A, Kato T, Maekawa A, Tsuchiya S, Baba H, Tauchi J, Kobayashi K, Ono Y, Sasaki T, Ozaka M, Sasahira N, Ito H, Iwatsuki M, Matsueda K, Inoue Y, Takahashi Y. Surgical Challenges Associated with Collateral Veins Formation in Pancreatic Cancer with Vein Resection. Ann Surg Oncol. 2026 Apr; 33(4):3535-3544.
Score: 0.031
-
Shibata Y, Jansson H, Kobayashi K, Yu W, Oba A, Ghorbani P, Ono Y, D'Souza MA, Sturesson C, Ito H, Sparrelid E, Inoue Y, Gilg S, Takahashi Y. Assessing surgical resection in recurrent biliary tract cancer: International two-centre experience. Eur J Surg Oncol. 2026 Jan; 52(1):111159.
Score: 0.031
-
Ito R, Ono Y, Fujii T, Takahashi A, Kobayashi K, Oba A, Ito H, Inoue Y, Saiura A, Takahashi Y. Tubularized Bovine Pericardium Graft for Inferior Vena Cava Reconstruction in Abdominal Malignant Tumor. Ann Surg Oncol. 2026 Feb; 33(2):1719-1720.
Score: 0.031
-
Sugiura K, Oba A, Miyashita M, Baba H, Ito R, Shimane G, Sawa Y, Shibata H, Kiritani S, Kobayashi K, Ono Y, Ito H, Inoue Y, Takahashi Y. Surgical Technique and Feasibility of Pancreaticoduodenectomy after Surgery for Perihilar Cholangiocarcinoma. Ann Surg Oncol. 2026 Feb; 33(2):1538-1539.
Score: 0.031
-
Maekawa A, Oba A, Mie T, Sawa Y, Baba H, Kobayashi K, Ono Y, Sato T, Ito H, Sasaki T, Ozaka M, Sasahira N, Takamatsu M, Ban D, Inoue Y, Takahashi Y. Exploring the role of CA 19-9 dynamics in pancreatic cancer multidisciplinary treatment: Proposal of the PANC classification. Surgery. 2025 Dec; 188:109783.
Score: 0.031
-
Shibata Y, Oba A, Shimane G, Miyata T, Tauchi J, Baba H, Maekawa A, Kobayashi K, Ono Y, Sasaki T, Ozaka M, Sasahira N, Ito H, Inoue Y, Takahashi Y. Prognostic role of peritoneal lavage cytology: Proposal for staging laparoscopy criteria in biliary tract cancer. Eur J Surg Oncol. 2025 10; 51(10):110369.
Score: 0.031
-
Kato T, Ono Y, Kitazawa T, Kobayashi K, Oba A, Sato T, Ito H, Inoue Y, Saiura A, Takahashi Y. Impact of Preoperative Diabetes on Insulin Management and Nutritional Status After Total or Completion Pancreatectomy. Ann Surg Oncol. 2025 Oct; 32(10):7422-7432.
Score: 0.030
-
Omiya K, Oba A, Sugiura K, Maekawa A, Mie T, Kobayashi K, Ono Y, Sasaki T, Ozaka M, Sasahira N, Ito H, Inoue Y, Takahashi Y. Resectable Pancreatic Cancer with CA19-9 > 500 U/mL: A Biological Indicator for Survival Benefit with Intensive Neoadjuvant Chemotherapy. Ann Surg Oncol. 2025 Aug; 32(8):5411-5420.
Score: 0.030
-
Baba H, Oba A, Maekawa A, Kiritani S, Kobayashi H, Takahashi A, Omiya K, Kobayashi K, Ono Y, Sato T, Ito H, Inoue Y, Takahashi Y. Polyglycolic Acid Mesh and Fibrin Glue in Minimally Invasive Left Pancreatectomy: Video Technique and Single-Center Data. Ann Surg Oncol. 2025 Jul; 32(7):5102-5103.
Score: 0.030
-
Ono Y, Ito R, Kobayashi K, Oba A, Sato T, Ito H, Inoue Y, Takahashi Y. Technique of Circumferential Divestment of the Superior Mesenteric Artery for Locally Advanced Pancreatic Cancer. Ann Surg Oncol. 2025 Jun; 32(6):4417-4418.
Score: 0.030
-
Jansson H, Oba A, Maekawa A, Villard C, Kobayashi K, Ono Y, Engstrand J, Kawano F, Ito H, Gilg S, Inoue Y, D'Souza MA, Takahashi Y. Western and Eastern experience in treating perihilar cholangiocarcinoma: retrospective bi-centre study. BJS Open. 2025 Mar 04; 9(2).
Score: 0.030
-
Irie S, Inoue Y, Oba A, Ono Y, Sato T, Mise Y, Ito H, Saiura A, Takahashi Y. Technical Guidelines for Safe Mesojejunum Dissection During Pancreaticoduodenectomy: Unveiling Critical Techniques in a Complex Procedure. Ann Surg Oncol. 2025 Mar; 32(3):1850-1857.
Score: 0.029
-
Kobayashi K, Inoue Y, Oba A, Ono Y, Osumi H, Sato T, Ito H, Mise Y, Shinozaki E, Yamaguchi K, Saiura A, Takahashi Y. Strategies for Recurrent Colorectal Liver Metastases Based on Prognostic Factors and Resectability: Potential Benefit of Multidisciplinary Treatment. Ann Surg Oncol. 2025 Mar; 32(3):1729-1741.
Score: 0.029
-
Hirose Y, Oba A, Takamatsu M, Hamada T, Takeda T, Suzuki T, Maekawa A, Kitano Y, Sato S, Kobayashi K, Omiya K, Ono Y, Sato T, Ito H, Sasaki T, Ozaka M, Takeuchi K, Sasahira N, Inoue Y, Wakai T, Takahashi Y. Caveolin-1 expression is a predictor of survival and recurrence patterns in resected pancreatic ductal adenocarcinoma. Pancreatology. 2024 Nov; 24(7):1021-1030.
Score: 0.029
-
Omiya K, Inoue Y, Kobayashi K, Oba A, Ono Y, Sato T, Ito H, Takahashi Y. ASO Author Reflections: Advanced Techniques in Robot-Assisted Pancreaticoduodenectomy with Dissection of the Nerve Plexus Around the Superior Mesenteric Artery for Invasive Pancreatic Head Cancer. Ann Surg Oncol. 2024 Oct; 31(10):7076-7077.
Score: 0.028
-
Omiya K, Inoue Y, Kobayashi K, Oba A, Ono Y, Sato T, Ito H, Takahashi Y. Robot-Assisted Pancreaticoduodenectomy with Hemicircumferential Dissection of Nerve Plexus Around the Superior Mesenteric Artery. Ann Surg Oncol. 2024 Oct; 31(10):7064-7065.
Score: 0.028
-
Kiritani S, Ono Y, Takamatsu M, Yoshio S, Miyashita M, Oba A, Sato T, Ito H, Inoue Y, Saiura A, Takahashi Y. ASO Visual Abstract: Unique Biology of Pancreatic Ductal Adenocarcinoma Accompanied by Rapidly Impaired Diabetes: A Favorable Long-term Survival after Curative Resection. Ann Surg Oncol. 2024 Mar; 31(3):1944-1945.
Score: 0.028
-
Takeda T, Sasaki T, Ichinose J, Inoue Y, Okamoto T, Mie T, Furukawa T, Kasuga A, Oba A, Matsuura Y, Nakao M, Ozaka M, Mun M, Takahashi Y, Sasahira N. Outcomes of lung oligometastasis in pancreatic cancer. Jpn J Clin Oncol. 2023 Dec 07; 53(12):1144-1152.
Score: 0.027
-
Kitano Y, Ono Y, Kobayashi K, Oba A, Sato T, Ito H, Inoue Y, Shinozaki E, Yamaguchi K, Saiura A, Baba H, Takahashi Y. Neoadjuvant chemotherapy for borderline resectable colorectal cancer liver metastases: a single-institution retrospective study. HPB (Oxford). 2024 02; 26(2):282-290.
Score: 0.027
-
Kiritani S, Ono Y, Takamatsu M, Yoshio S, Miyashita M, Oba A, Sato T, Ito H, Inoue Y, Saiura A, Takahashi Y. Unique Biology of Pancreatic Ductal Adenocarcinoma Accompanied by Rapidly Impaired Diabetes: A Favorable Long-Term Survival Following Curative Resection. Ann Surg Oncol. 2024 Jan; 31(1):514-524.
Score: 0.027
-
Karam E, Hollenbach M, Abou Ali E, Auriemma F, Anderloni A, Barbier L, Belfiori G, Caillol F, Crippa S, Del Chiaro M, De Ponthaud C, Dahel Y, Falconi M, Giovannini M, Heling D, Inoue Y, Jarnagin WR, Leung G, Lupinacci RM, Mariani A, Masaryk V, Miksch RC, Musquer N, Napoleon B, Oba A, Partelli S, Petrone MC, Prat F, Repici A, Sauvanet A, Salzmann K, Schattner MA, Schulick R, Schwarz L, Soares K, Souche FR, Truant S, Vaillant JC, Wang T, Wedi E, Werner J, Weismüller TJ, Wichmann D, Will U, Zaccari P, Gulla A, Heise C, Regner S, Gaujoux S. Endoscopic and Surgical Management of Non-Metastatic Ampullary Neuroendocrine Neoplasia: A Multi-Institutional Pancreas2000/EPC Study. Neuroendocrinology. 2023; 113(10):1024-1034.
Score: 0.026
-
Kobayashi K, Ono Y, Kitano Y, Oba A, Sato T, Ito H, Mise Y, Shinozaki E, Inoue Y, Yamaguchi K, Saiura A, Takahashi Y. Prognostic Impact of Tumor Markers (CEA and CA19-9) on Patients with Resectable Colorectal Liver Metastases Stratified by Tumor Number and Size: Potentially Valuable Biologic Markers for Preoperative Treatment. Ann Surg Oncol. 2023 Nov; 30(12):7338-7347.
Score: 0.026
-
Kazami Y, Oba A, Ono Y, Sato T, Inoue Y, Saiura A, Takahashi Y, Ito H. Intraoperative paraaortic lymph node sampling during resection for pancreatic cancer: evolving role in the modern chemotherapy era. HPB (Oxford). 2023 10; 25(10):1169-1178.
Score: 0.026
-
Kobayashi K, Inoue Y, Kitano Y, Sato S, Oba A, Ono Y, Sato T, Ito H, Mise Y, Saiura A, Takahashi Y. Optimizing the selection of technically unresectable colorectal liver metastases. Surgery. 2023 02; 173(2):442-449.
Score: 0.025
-
Ono Y, Inoue Y, Ito H, Sasaki T, Takeda T, Ozaka M, Sasahira N, Hiratsuka M, Matsueda K, Oba A, Sato T, Saiura A, Takahashi Y. Analysis of prognostic factors for borderline resectable pancreatic cancer after neoadjuvant chemotherapy: the importance of CA19-9 decrease in patients with elevated pre-chemotherapy CA19-9 levels. HPB (Oxford). 2023 01; 25(1):100-108.
Score: 0.025
-
Yoshino K, Osumi H, Ito H, Kamiimabeppu D, Ooki A, Wakatsuki T, Shimozaki K, Nakayama I, Ogura M, Takahari D, Chin K, Oba A, Ono Y, Sato T, Inoue Y, Takahashi Y, Yamaguchi K, Shinozaki E. Clinical Usefulness of Postoperative Serum Carcinoembryonic Antigen in Patients with Colorectal Cancer with Liver Metastases. Ann Surg Oncol. 2022 Dec; 29(13):8385-8393.
Score: 0.025
-
Kato T, Ono Y, Oba A, Sato T, Ito H, Inoue Y, Saiura A, Takahashi Y. Comparison of the clinical efficacy of a new prognostic stratification for duodenal adenocarcinoma with that of TNM staging: The importance of T status with regard to the prognosis. Eur J Surg Oncol. 2023 01; 49(1):122-128.
Score: 0.025
-
Omiya K, Oba A, Inoue Y, Kobayashi K, Wu YHA, Ono Y, Sato T, Sasaki T, Ozaka M, Sasahira N, Ito H, Saiura A, Takahashi Y. Serum DUPAN-2 could be an Alternative Biological Marker for CA19-9 Nonsecretors with Pancreatic Cancer. Ann Surg. 2023 06 01; 277(6):e1278-e1283.
Score: 0.024
-
Schulick RD, Oba A, Del Chiaro M. Response to the Comment on "Prognosis-based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines". Ann Surg. 2021 12 01; 274(6):e770-e771.
Score: 0.024
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|